Immune Dysfunction and Immunotherapy in Heart Disease by Ronald Ross WatsonImmune Dysfunction and Immunotherapy in Heart Disease by Ronald Ross Watson

Immune Dysfunction and Immunotherapy in Heart Disease

EditorRonald Ross Watson, Douglas F. Larson

Hardcover | September 24, 2007

Pricing and Purchase Info


Earn 1315 plum® points

Ships within 1-3 weeks

Ships free on orders over $25

Not available in stores


Current heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years -- suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediated cardiac remodelling for cardiac dysfunction.

The outstanding editor team of two internationally recognized immunologists -- Ronald Watson, who has studied heart disease in immune dysfunction for a decade and has a patent for an immunotherapy of heart disease by immune regulation, and Douglas Larson, whose experience in cardiac transplantation immunology has provided the foundation for research into novel therapeutics for heart failure and hypertension – makes Immune Dysfunction and Immunotherapy in Heart Disease the definitive reference to the state of the science in this area.

The four parts of the book address:

  • Immune Dysfunction Leading to Heart Disease: Induction by Physiological Changes
  • Immune Dysfunction Promoting CVD: Induction by Transplantation Drugs
  • Immune Dysfunction Leading to Heart Dysfunction: Induction or Prevention by Cardiotherapeutic Drugs
  • Immune Dysfunction Leading to Heart Disease: Induction by Pathogens

Both researchers and practitioners will find this authoritative volume an excellent source of information on novel immune targeted therapeutics.

Dr. Larson and Dr. Watson have worked together researching the role of immune and cytokine dysfunction in heart disease for 8 years. They have been and currently are funded to do such research by grants from the U.S. National Institute of Heart, Lung and Blood, the American Heart Foundation, companies and private foundations. Dr. Watso...
Title:Immune Dysfunction and Immunotherapy in Heart DiseaseFormat:HardcoverDimensions:328 pages, 10.3 × 7.35 × 0.8 inPublished:September 24, 2007Publisher:WileyLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:140515568X

ISBN - 13:9781405155687

Look for similar items by category:


Read from the Book

%PDF-1.3 % 1 0 obj > endobj 2 0 obj > endobj 3 0 obj > /ProcSet [ /PDF /Text ] /ExtGState > >> endobj 4 0 obj > endobj 5 0 obj > endobj 6 0 obj > /ProcSet [ /PDF /Text ] /ExtGState > >> endobj 7 0 obj > stream HU{TgO3 f09jA*T QAQHZYk-.PkEzZ[u^vNl{gs|s?T&J?U?/TS''uNS{?Y 8 2J&n4^:A%Yr~¥?i5Jbg^RTn([+mhwp96^%j?:8+g/]bn--?nJ? 6.)E{q?BGiq^js N.KR%vikY&]?vw?$IrU''H~ZD?Ud+zow== [A ?/W@>IG kW;mz(z4p+{v?= Yu?}guC?V?Q^Z?*D%+OA=n=sBCFo@ gx :E/bjX0!h@{!1_`/99hC$k!% H`X abl"Xe uE8u&O M  Z4L &`)x-6t1[.#}[/WWfLt? o?qts 1?08>=,+?>@ z2Of]l!*PGbW VxHd,$P DY| (1FIG ZHDT JYJ+h*?&dj!.v\s|/O[{F/Ypi N?4 ?QU_CN?@ _Eg{RX{t&PK+ze?8t "OW?mgx3?,dt[>xv)?viZk?#_3 U''3|O(?kJbLk ''0lc  _??~Lu/iTA~$ +N-/ =^J?w >{ )J>Ü'' {[ i }-*"p@iqjC?Zd H)38 A0D? E?Djc^?=T+ a$ SWN@7O8\E[`a9HC:K `fT Gr%"e?f#@kEzY4 CrL0^_AU`&!9d!T uG]hb0?/NN???-w]}; fG>5\Yx6&>?2 K$, ak6X~ ;q4 a6cX&ßlN:k6C6i=x;5| 1*Pf(KBQ% IU!]HcMdC''x8({qI?.+Zv&M22yvIEh%Ds0K@ey? ??yo2p=+Fyc) "?/j^?CuoDK}IcxOh6lDSu!Xb%Q5?5R?G! EJ­?`?TKd` s]?r7D[dN0o26bM''ˆ5x\?6.c}IU*gsXCUXIna=YyHv%e evm 6kri?Q%@N|# Mo@_3$W, IM&^MCZ>LI$?K@zNc$c''MMMx[>"HYT???9J!F0}j$ATY#*/T"H!3n ET#2i8cOq N5^Pd5 T`n{|^(/ btBI(jFN[HAC >!$gM#C? ! bVxgs?=b{C ZU{Ffr s&oFJBK]hFixqf^ P%?y@|Qm#b?!$??o bb"T|2: b ry*q~BUm[ 9edpHPCdRWW?]XBS yrP {CRO\pBk2DtIGlRFa+06`|"x''}iXR9q?;vR?[Qkup?EPP~4{*Rt0^A$>Da|qBL$ j?8?V`E/J7?%#V?;@02@cLo?0 lxvVP` [0f tq9 D!2f(LPvN EF2 f2[A|?Wf_?j[fJ|8_\. fTb]ÞjVo)F3iczTEjaXr =@B1966JE@)2{oi_sl6|`Rsl\~j7uu_}x/D:*]q,ClAM {.@V0:$ HIZce_f_wUg|f)|:??\?:CuselnNTk7U(`.wgLs?RVY^U\ l{eg0j^T/tRGXIb{^QQ\g:V?;"3Jj(E 1b4G +J ( HMh1kOa5Q[Nw~D/=2)n_ch8h?|/H>3FmVwH?!5 `!TRb?Ü?J*q9 ''(G?:|fa0$az o*7 gTb(''n"BDD"Dy3SdEZ[p >X@*e?8?%94p,XYB(DSTDL&SDEHHDD\''?* 6Knb\''=|&a218XE$ u14;4*28)C+~0NRDr6InA2M3 C;-?KW;0it/)9?9x??c7k~d:?$vxdJ\1p~6A.}}2Lh`#3oe./Z ~ 5d(qcL?iX$iÊ|k=e:+61AIH ? L_Xm)lRG 17f=`{2qYFn d2L~3+??jN8$O>v)@cWS#=B p")DI0niGOCW?aU %Nn>aV}?>?. M???jb"EADbS1Q w:?RX PJ_?is l7E+8V8?8?7?.?xB0P0?ixP+,r?u#y nl?JNW8E??VGQ!J1OV,ATh)*G6''&2sm$=ph?3f0P%?hOkVo %?}+ 4WQysv79{d A-A1g^0H:cN?#4 {J_ | fj`j?tsP? 6?V?hU?T:R`:Q?nc&"j_QS:fu3)]^{s)''fYVcVlI@''DxB6SZ ?#\d@vW^-dDYJL=G!:  @sy?6j2ZMJu;?24m O?V|sKc(x *:Üvv:??{O*mm?ZSU8TqDyik?8G)KuOVr6.cra?m?Hy;''N t ;}QPdk1?_[?@T?ARS ???Ky?z:1N#~B P)HH81F qW9dbI$4??^I*?e?? y(R1$URQ4?'' E§f;k?4??-ot $~1=qv.o]^.T4\%K &a0Dx?$^cpt?nb2Z\b+; 6Hrw7BA-BEAm[nl#]I]?}&ihHNk`tE` w[mpK*w7m9XZO1O)IdV 3V D>R8?f?t@u+`$\= "0P`@`)}HEXH?:X"0P`@UHsC*D`DA wqrt9n:?@SxH > endobj 9 0 obj > stream HTPn : ?R>v''H B?qcsSf|ps\"8m>$?s? C(9 [q#.W tKJ?8a @kp80~~1Lb5!o?E2aDPRhPF?vF?oCl|;~,8kU]**T5~m endstream endobj 10 0 obj > /ProcSet [ /PDF /Text ] /ExtGState > >> endobj 11 0 obj > endobj 12 0 obj > endobj 13 0 obj > stream HUiPSYNH^C''yAeQA@Yi!QT { [@6 " :"HK?M+k;m=V3s}mgjjj[{ws?T ]BR_F''D, ÜqLd>cjki?? yh''Vu>[7701PQ,6Y|do~R/wA+ ZfMfwD"qMTL,hr+Vn\9bci 3oAUW?(YXfYvXZi{k?i]V:+?:;le?\?a~ }m|i?zeF6c?../\?j7,/:+_m2qs5m^[/~M{]Z__?a?-`g_~;gBf%R?w??!Tk?_DH"s 3?[E Jr Q@eRu6[kjqN11_=?#d*''{X~@"#¨3`Dsa@2l1d`@e  ''L#g9L?4LYOs j,:PB,§}zW{z&IC 7MG +~Flp]]?D%L1DY! l$Alh9i0S\S5cR++Kz eJR-Nb]@2J h@nv TQLæ{ ?ul`"Ah?Y @O~h @OOh&ZLufW5:, D zf6e?f vS~|lo-sG%Bu)a  \?rz`?a|e=d^?}??hb.Qbrx??{+[mfV|=`m]|ir3=$J+Z|oxe{kW{UUqSYbh0?Z Z3 n3_{C_xa,Q?LEbe;qm:>SM:''EB(d_!AdP:&;!Z}a^zBDxrt]V ^1hM-2S5?nN??:?L*:;+I%Ag H>g3v$l ce K1X3o?fH:`q´[.5?Y&0~& ,aI#QH8TeILo@?w?u_aq^>paRt,9?^L?TxB|Pum[ ?Nz/e4O^?/Jio|\^IT)Uqf}9A5ob)tp>WBD??J.?w8II*UJ ?G-)6|srXQb7)/R0o+@hj#G^`11|?J(zg5(gfF2FyDBcr?d|-8Z* )\>"i8Yof~5E^ 3mL nwa?Q(WtICM)\-|yZK??M5q?G}dM101 Fk?LM(>l G~}iOa?R?JW\3 ?Ug4PDgZe!&7VvtoZVpzd~::/ ufbd_MEu t*h%C.[_ nU?>%SS*@G e6=~0nG&&G+)`!V#/.Ck#XP0l=Pcb\bfX bHr6?=,q ŸM?h.,j`fZ3 lda''?Hh2;9?Gc/?- q°:4]U?}V o3Ei3M.|[F^n ?3q{ ?PZ.&.C }R;#?W|w0@0 Fh%Fh-8W)6/\.x : lbq0:e9b*gZ|$P,q>u1Krkah cTTOnS!VkS\niH??&]6}Gd@; [#*1FfIJ?:k0tn{U+j09x,)M;j[KW ?idH&Tl.>?/ye#l}AP Gk:{/^kgdS z?.M]4EVG@8q) 7i0Z G~!x_9,j?\5rUUV)O-z8@omG??zJy/k?R ]+u? ^rSuYZN?FkoY?-?}29V)Fnh--( -8)G+~,?P-l?l$1>''4?KD^d|mK?M Xb7??(Qf?0$u2jhp5? &#G/im`1j,oR#Tkse]$ya]TuXOZO?OlVu>%?6 vnVi''r b.8uZ|Sp e7iF\B?m"GvA> !vl/nY!2u>sIY/qa)faGR5l@VH(*$? s ezl_6!6rX1 ej;uRP|,-02,7 R?9]wZbp?=`? cLuuzLLW0M]9, lRH%`:3SI"3>0g _dQ[)lM^Yk{.nK?C`,KY[{#qj4F0cx2.grq''~Q;{F*o40Cx5agN~x6&g&:?3Z3?Q? ddE%''?{HBH?Dna P[k]Zwew.:_?''i~3^s:j&z5 Vk0,1s?vv|?lU:5 0" !WT>\T?a>=8 sR.Z?Vx2??Dd_s8D?AZ?bCN7b39(( O#k#}\@dB8=eO''?xW|:AP N::ts;a ir61!=uYl{\O7K+:4H D3BK4ZP>j_0"N?g[k`iTS gXK?f{!zo?gr v''/ $g!?I%f(I BEUq | U?z`=%`c]z#VI B+HZ(dy.CV2?Bj??.Yd4SoY?KS?=K3?&i6C30am\1t lFhW_f~ 2m?T%Zl_Tq p(.m3u?4C?''| Im?gi|Z4^F{u9 {}XY mBnn2W*_} s'' )~*%$m&|.N'' 6/L4GF PkdF*t ? ATk+??T6{ Pv?a8>;cAIWVy?uF::\/#YKO+?SVH{@?`jj*;Efk?;?N8?]uG\YD *@HB^7iB!HH@ =)TbW#wX~dKU}x{0F/_| Fg?h+?J )1e?n-0Ÿl0,{E?X8V)? UC.TR:|^ `D\q2gt?u+Zde 92^~qZQ&__-8 ? QSs g%=qYc%,G34''W6Mpv,Ia`>uQ=3-]A a>J1;Y>g/`8W''n`O0kn?rL"k*xq$_Q)97` e?\I1 x(qg>?FgH"IW1,#?;1`1OKit]"~)"u!4[?m-^d9R km 0OH&e|)GN$ErEJ$¤s?erN=?BsnW{Rs+EMM1a{oorTs]?K!{$E gBL|yStjkYayM 9."??(QlFkFK&E,)rK^T5ZimIKL566l.8kat/QAaGQ S^ =*=S9G!a^J %w&9qlNY`/Q3KPBL56(FBU{z{O_F ]*Ru%S6q1?) pUc9/xcyaXmA fAz0t: 9?^X}3;>OM`O@''k!)RkE? R\?.d$67E^hUXCJc`i =T6c2-03r7RI[ =Fu0f; gÎIOnaAM_?bI.GbW>vDTLkãaOSWNB;FI?uIbzj3A7x^6P?:yM?z!tPH>c?0R(QyHHc3?} c`-/{/yhD2nA]:>!CdC}!GCi''|H!z$)Ru;j?Q?dvL=!Q:]? ~v [^?j:B[{*]l[d?? @Jv">/ X&IS''AUo,6?W C}cT~2eFE5f-j4 riYAA%_;+z:J-c3|S+1C }a?_c!(n^_b4_ gW:zOs-eH)O.¬%k S\[a?6YrLye%:Ze]\??X 7I)l,[h#e9?Z S>2[-vm/?Ð\'':;VHY:UBxG!/ o!E@@D@xbE,?vQw?mgC:=X9jmKGJJ 9G|Q.cav;`JL^-_?1YcV5z FT&[?y5n?] 7`Eke .Ts(:|:^F{HY3#4 4E.''?)ACA?C,gsE 4(|? R[yC*q5 )Eq?m7.z]fWb:[-jI 24/Am`_uCrz mV%6?1vQ[`p" {#>>8'' 9>HO S:?>yO p3maakO ?93pz`?DCp-~n]C} +G1I| $AB;+9 P?0P!r*p? l:6 z #./{`tb?i:~HF7&z?TrL{Eh`TqdR&r(u(E?$p7~p??77SMC!V\ uf3>,3oH~z0?LfW?2>[k0PD :?jz??'' FePx)jYue9"-!e???Q^hk YpMN\37A9sO@!) T_GTj4~3]e#{b,[+z[?LBgNS KW1i-}oP w:u?.e8?}3r)hv_?K@q),C?Uku2w?]TCQ%H $?/1VkP%NB%!i,NR] )N#=U R?!R4Z&b }lg ^E|*KaWy/8{@T? p1x;H2|`l)drwsZA.gO?aCGWgX:LSUEUy?_?P?@,/PhL?!i7i>~?HQk)0Oio^$dyz4o20[4l! $TVX$ |3FOO`x?Jgii:4$p&}Z_S[d=1DThlxE `XQTC!T`o;?v::q ?J{Q+1 6] :]&[-]Ef.U|vaSD?,}SYT1]{\YnL&?+ VcY U1h\dhdoZV=Yz!,wAbj!w;gwc1.0pRP&k>p50Ti-?Sl{d6 uOb_ 3.~A |b1?++0 b^9Rinwk{kO a^o[?_57EJA-"pupx(o%8fwl&>I??NO>aK3o|8~s?D''zbcS7%P^z6''a2(?QX¬K`D~^NW)Q( 4l?0KlP?_UF^5P? #b;\[dgB /q$?FMC(*eu}?;_`Iy)?]?e&W?$#sB?Y/NSGD''$_Q2~`>udTU\ZlS Y&.R,rbzbWZ?G G*u;OQ''??0?n?n;?>U[uQ {yq?VEFeLJ!8:2b[ae"a,O?\-#U[(t?9;x(&lBK((OvJZ+P Tr/Lr`EF-R??~jMX&eB''?V7M%K12E>smx28n?Pgg@!''e!: 0Pgt@,or?Lzi:[a+''X8FSb?=&dE82[`{ %xC]q>Gk]]9v1ViAg];=buT$?8ebx[SD1@D69 ?}*PEOa}*,K*z$/d%m" 1jPz2BPo&#?j ÈB 3 WO Y0`MIEBs~nx:u>gk(?sm=: U[s(C ^$\''`5 |\?.X?­|a6;qj)!#D?|R8"ccBT*U?mZ?oM8q}S9iV5V7|DPC!nK~Qs`x,6/°?j YZTbLT }{\n?t: ?;?m+k+uNIr28de?!E?no. 4i.p2DzLT8:2b[ae"a O?rFj9oo ? (&[?Z]BdLvwQ: -P U&| `QEt) p{} :+\O8>%?Hl$ FKff~yt~O -++r ^)b7Jc?#}HY#CZX` ak?llE~*ZMYU(?) yBE!bWwG$^7GVD8(QOL;"??q~d$3/sKz>Np`,8 ?V(s(?+8:?Lx#HTd~J?Y''X1|g?^}np?g?n endstream endobj 14 0 obj > /ProcSet [ /PDF /Text ] /ExtGState > >> endobj 15 0 obj > stream HtT{TgOHf >j?w/ f.)Bs^M?m,>#!C_=" 0 /87Fs?Wh2 19DtCX7FT(Z!m|4XA MFr1MD>h9 A# E%^"|3k;V+ u8''6E:4D.HrsT86>l ZHm` TT@`#x jM ?PpO-V ?4!q9EU77t*,miCK-L7,Ph;->oX8 ? 7&C%nju |?dF?i-X?]? 6Rp''1YY7+GmO?@?PN|xy w8}44 G4,n?l8+Q?, X3w+xCkiWJ J!`u[eQpTV=#/@2w9SE{axNxSHv O( ]3sxkSHYP?|SL?R)9iq?Wot?4)?:sl-s Op{;@&{a > hIB1? =*:y>yn|F3"**(?XHCBQ*8k?J7GFjM$J$vB+u ),s],w[N?|d6E!fOP F ?N sc?_%_S}Tw?^zMDQs[] [''7`m 30Eq8 ecHcm~¾Ir7K.[?S?0y) Wb.CBan+a?O hE?|g?od0C6V00,wF "% NWN30za?K .o ??>>o\R!/?c''| %(axD?&ej\UwES`DI3WA\[cMdU/CZ/M @ X%@I»3 jT,|%fs9?w?/Tq^Eeb*p`! {jL `Z{''QE(:.?sW8.f+n!a vQgI:YL?2RQ`$A Q`:$Mho?IgJeS6Y/xEX!~nMH@?XQP$ ?CO8OKq /`/ kkt`10[xGmq|giGH??UghSmt^:gVG+Rt;bt`?Y>a@"wOioA*(# nZB^1!g?e9JR;cF? " RR +mdo9Kl?eq?egLPL?O?B [f,gb ~t75? KNR+~ [>]JrCwEqeLv?\?JXKDQDd3 T`D@PDdyQ 0$ h,c\If?FohT? guQ\#vml\m ??4r4@!B_TMSRE>X*c~y{8#~%br"?Q?a/$R?x#%r`D$yd-HMK''bP;3*_/55d>X1 V Ds=q%(33 ?? -ve##pY$dc"wl) *cT apaXJA:Ku$XD}8J $G7VI3D__&Khjje/^h=?vCEZ ?znAS h|u?QhP(uQv{a+EL\fl?\;1cu?%1$r"y[?]0^?|XW\~Hs# bV]n .T|8UB Zhs D6U`)RXJc?/?\&.0{rXH[#  B8 b??)?m?8[9I$)u8FS^]Ây=PS3hl; u!?''F#}_eum\p0+HNT>$q/z@!3; oqa 1e6tQ*~`* _i%BTd?>;u.[ZS?Q?Tr?D,y''Q{}?3TW*$>f&gk;G% !DC?YWX,[Eu1G?|q`f?=uA M;RXK*KT?mHj|o* #U+8h ?cRwpF`%OcFI+Nv9Y?^8^/]FS;S;cWVSn 8 %_3?*@ dC1e\@fto %??9}n-iV l#"cXrB;K 1XB;?jy}p?"s 8\@47?:h rhClT·\P?D5&Bo=z*[GnO e?YhDP+-`jqQ_I62v?=lOc]w6CË 8qu''xw:?%D!i-^?M0RrF? dV[bE\qY-eee$ ]Mr?Em%6bOrr?e N$m+rk\V.6J,,S~yR`?dUG*B6 cq#B:xcUK?csKV+CRw K?ThH ?gH?Sx =1|g G~a|b;La8|KM=! |Fk}|Xm82?g ry PAq64JNv[|wy[??nV3?sT|WvvS/J|FUC?~A?:wh8C''b?xvWO;2h2}x[WE>m?r7;Y`5N.? ]SQ9Tt3 Q+(Ie_:?y a^yC70ao0x?`|F?VHFD&Aq/}2+v] B0j3QD *qL|&x~xuy{%3[n?9{?wBX4Oz I NNQ=*kT=H PAYZ0f,Y ?Bn''Q"+eUM?7/(?W.68(, ? ^/A 0{Q9{UiA~VMM Wj?5]?91?P-i%k44u*?`??^6,-K[c;KS8y?Qz\o/7b? ^^$@ ?:|nVIR?jE :}7d(IBL TF ??g;h-B 1?` > stream HTPn0 t?%Ey N+)}%I?$x?!A?#t,''67AQu&??Dn1P? > endobj 18 0 obj > endobj 19 0 obj > endobj 20 0 obj > endobj 21 0 obj > endobj 22 0 obj > endobj 23 0 obj > stream HTyPYNH~IPJH D?p) r(" .p  uKM e\a,^67YfI?)?/4}*!FA+dNJ$?,&r9\O? >%2JH?i ??QK/R2e-tz}rVHW|X??,#XObXY&^a5 f  ?l*G LyV(h\4IEK?¸@AD@''~D:?CCx QA?4.}gat-oTsIwG8+|?M%jk.??2Go+l//?zL?4w46wvgGp?/K1c''`>y &z 9x''f@2C`??~?(h**cn b? iBx*G?pm]wg/NG!8oh|e3 +K9]9=I!2:8x`}/Z8Nw!4NShb!p??!/r@^l5g?Lf[?@40U\L\ xx7`e &ay5~ 5V0)|U4I3e_Y ? 4 |S3$)Uei0 #$ f\3=;piJ:t>j0z/xxrBTMc7ao­g1\?)=Wq?=ji? A2 ?FR}|1.V1^=H?vq(,NQUC%N +r:-jFi Zu Aqs9^RK%C#''?O^K"z''h%3Ja? ?o`?Ag;ki?pB/=(*^{zs(%(VO(:5\KUh$"UQ{?]_,r,N 7''bN(+T[ m{GC]A`?  )_hwa[X|''%?"?p3M?sTIo?dt,.C`> CN q\woiiz}WguKcCCH 7wv5? tWJB4YDaah}`B4ACF!0l$LZ5Iv/A6h? T,5?1*,@D?=-c)&!TT_YV%&C!oG(S0dM.AV^NXxq;_)J?1w \sS4*^IiFKi|E?kKOs$?''=bNm9ObZcg?K5zagg?X9 @S?.GVqS2?0 _ ^:(BS?3S?üq^_mDcq`IaV)PQkoK''|` ''}?cQ3\9W{ob';j$`z?lclA ~?.aQ@LC?^,-FL@CQXd9{$?{w[`EEO%v*U ^0N)?#2~={S)&.d÷[D/cE?9\?` #Y49M~2TrKDXN%gZ zmsf>%2W_M5?G9K{jjJ6}8?fUx`LpvX @ |]Dui"[X xt p 8-Iq:,h-)~?] 6 o% fso;sha/a2zpnHrZapSA{?CPSG"pyFIND8 %r5?W=JLA~BO& pP?fhq1P-9]&4g!?g^J?bKZ1ˆC3Y^a^UvWJ?U f|NO3B^ upm@,?oK+aaX} g%"ÐXov:_qj` A7R}?f9xFy4~`)TA .?!63i"B}t\aV sSV G@UM;K?''1 ES?\ Z{?vt2e=i?@(H|xž `4vC''%$?}%T0X.k?*?CC)g8x`(+Vg8J]Vrw@P w}fR |ZH{O3?(`oX]?1/o!\q}cC RDMeLKa1D/aJ?[?Z+KY?B)f%VOD9RWi?]  xS(X@@{]AST?IkQ~B` gsZd?""]zJg\q?#_#9X=Yu]o_..MYxR|z88N? -)v= mR)?nUk2A^I?q3 } 1`,rl>Zde1!e%p\fM`+vEY:Q&D/Q-je IWR/  *[ym6g?2IjV@?j;.6 G?D".9=5JM.-4; u{61 VO|N.$iR>DQR:"RV\Tk Nz+ O1U.CFc!-,(!`JkK""2X?áohBZ t,`G? mR^$9\A^ [w[#3(4? ?eAJxgfIN8v |Bg zxSO;b}&wg^nU8Z?[3zj `$ sp7s q?tj([yjA cJ)JsRc?ey''!& MWi:M;0XN?M?Z,_E$mun xt_H?T*Lc= {]vg;?g E|&K#F"K T2 P?8} rz=,:8?W^*P?_ U cb5{`m\-tBYZ>Sk;|X{_pR|'' '' RI>~X>&t Ce ^a^zL PQ\?4n N yR bH$^1#T/W5[nPI 24?Dy^$eS$q`ZsH y ]?V+2~/8I*Qc?M/1q 7TNA `U2 #;v?@rZ~v>\t8h-@zmPpe3G@%C0LI]-mVVhb'' O K]`jCBiS Rblol?i=MePl!.&;F)S&*9oAt[ 6HPfr%Bivaicv[ +U?|2AlLJELfb&rjZ''=u x/+)G?e"0k;t?G11{,8P7I[d ?KG%^K )|lJ?)©PIdCz'',mgAb`oE;SWs2zeL88n 6ljfci>8vLl7a!H$t tHB8H`i`#vn4}U3Uva>}."x_;2l9''3G0Ud?n$???k+[#0o?7-1m ! yQnK]k ANo@K$+!s#gj2H[ RFc RH wN !HE@gF4 v''7(+ 6tuynF~Ls\Ydi+?vP:?4VJ x=K?j: i:A&J?[A \TD?HvI ??cvl6Y].rh2;74~)dOA''f!gF3 tR=??|^ X?UL.nGd*?5:p!L`d} ?H8m~ )?Q:2X?K?wb(jpO#l Q[1y,)18(;Gv9rp''qKaK8L"^T v!;3xl{S*S^Q/y!f?0gc$_Gw?$iO |Z)?Djg7)s&E^zA?~N{swC^s649v;fUs(}qyMI>-ON4 J([?xb/m NyQg64*x0Ce''[G &|?SVU?k*f;t$_ D2(YN2$.SK}AO±d''VH?pGs- GmPwu ^DT!_0-HNWF?a| .fPn\?d-@ ;k[Sz''5`KP?5@OQ0b7f?Eg4|@?w5,VRj S''a`m[Sl8u[`hMp[YUU7~_]2LfWc$`*|jjd1$u-xo^u|?n*?t->A^Q A$@ @x@#@ >cVnWV:?nwf?;n{|X/22W?e\u]&''T?N8+?_E $V/y":),:*,cpoHLfFD`?A f0v?_ =(PHTfCI!??g''&?N4?zupme |he?=CNx/xS%? eTW^ D^W`,E%?á?''''y md$tP pb1+0"boj*p[z}+ &R$]gu8S?ZRd?)``LM?+>[9?|J[UVO+JU?YyrmQ=  >{O^,zk-We4S~ &LJ7&(;Lf6/.}vS Fm}Z::?B]n& |O0f,I!yYtJ1"gkD.:Tu{+x{=@ o4Pp?>SsM:%[(u7ans8.F++.  lR&vK?>q}V` Y-i2#E}f-?L7(d??B-8Z|eM|Xy?S9?oJ]b?u*U? a y_RTFp`?WWMUI\DJ|!§drgzeU+#~azs?N?p~f/6V$m6r3!Wt_sd>|9q:KQo6i;@o\Fgf=iHD~Xft1\Qf)&jn&M8PEj67Y dwhR]b47lc@Or+[9kU,^Y`@YWCmO5?#[fTwf?37?8__c#L LO?e;"$A:S0v?tCoWQ8?gd H a>_~??1mvkEM#%B3Y `na5#n0VQ?/5]Niu .. .TE`:Z "?L"gm "yC) Z9w&.2)?@A VuvW f/[ ?pk2"?AvV76UQ[liB;2;?qh[+:N;{{8d9LijI i:! %?bncIt5è]1 1QZoQ+D`vpTPh5: 3ax731O?fq. Cpqk|?_Nc=pßHP?s>5 7?t%;(@?2=ûm?.t???^nWH~7?a]IRheH^QMw'' ?fJr? 9?=?_ R7!@t` KM #!@/U@0bjZDj*^t=gn?y>|@A^jsW.ZI%n!mRsXQabvWJ;avkã&/AU(b/},-36RbNQ0Ta2.:)KFM/XLüYaRP|5Z>q ;-?RUQDo>+}{? Odrh&G/''e ?W#T(@g |uJ.?V 2#''>6??C5vCgX}X,#J%2p}2O7t0bm{9L\? i|''c1~^B)H J$mBW?f^z>( 6N+Uz5Kkwaq.a?Ft?#R|NQ+?\S!l~{!\B-)Z=rbq,pwQ_s*6bSEquLR1Z[be2sB/ Ruj''It zmH?Zo|_Mj ((3 0&>:Za9AK?|F?R 7^ lg??xatdEB ''dlH?.zm%Y^*k)AHI{ypI#}go7 *!?dnllh^Qzss+ZZQ/2*K5ye~9:lH]fk?k{)C-8??"T.$)D? =/ 8-Z.1kY+%2?R1|QEUO+ n rT0G''+>$!U]c#=F*Er8cZl.  }R]E$''[,0)?T9RzB&{\pe*RTfd%V zQ??z7:g 2xO,>vn{f;p>E8j?`po??b4A=S5?vgcz$I?\''.J`{l?^+{\vJI )309%&,!m.3FNH e;`QS2?XYjHR &y3 ?SM''ZVR[|IE[Z,[JNA7-|MrQL}d&Ko:i`%-CoCvR1LE6iKb??fG!Xl 26)? ?4%?$akl*-]*j*nBB,&MZ@?&T"Z`^5BlSDidbXv)WVALZ3&K%I?ZqYQ8^T~ JA; P6A7n aM?:&IH+zgvk}]sd\t75?g{z :H\''F]dHHz#AgJ~ KDDX2>^]M#1K 7K%Y*Q*tG?U&f.:|o?IH \Fcj>J%5:]az ={Jrs^~?0(d i o1 ?7j.j P?4?6!b!WbN`?~:=2{??)%M|fdT$7,zY%Ow{+|MblI L?BIu.bJeK`;tJ iGX?&,l =ZMy ?b$ýcL ]aw gq- ?;n\>%8:,=(iIG`]Oc?m)$N@vDF#PfWetYn!8i&FD cV,~]#m>+a_e*u 0evbhx0i?7M!ulvD\BtAax>qx/+>lg?mp&?d7?n?G Nl?^@iT?%P?d{i,kli:-Jiw-t\?eTDU%A,89i.p)\Oqjc t8m R?U¿jR rH*qPay?~8S8(a?mkj} `M1~ko8Y+40eBZ2?W''B6w8EI`b/8??_k'' > stream Acrobat Distiller 7.0.5 for Macintosh 2007-05-14T22:14:08+05:30 Textures®: LaserWriter 8 Z1-8.7.1 2007-05-14T22:14:08+05:30 application/pdf ioh BLUK087-01.tex uuid:55d56992-023a-11dc-b42a-0014510bb9b6 uuid:55d56e74-023a-11dc-b42a-0014510bb9b6 endstream endobj 25 0 obj > endobj 26 0 obj > endobj 27 0 obj > endobj 28 0 obj > endobj 29 0 obj > endobj 30 0 obj > endobj 31 0 obj > endobj 32 0 obj > endobj 33 0 obj > stream HWr6- CAOlGQloVV6uxDis)sÐ+?5RFq''?|??*e /[1;pEo_E?rFQVv  ?3uy!~ph,1wn?hc2ahB H$sN/Jl| ."PxQ/ hwIml-O ?m;NU?B,l7P# hJp6x+c8d*Wf-*&"P?+?5v wR5ewNP5Bxd?Nmflecvuf{DR?PY!7-?] K85F^lj?;u ?!A>N) v ~"IO]?,H~&Y`jmz0@#Se~U6owQM{_n|T~RDEma $?nYg8?-Qma @laBm?q c #z\?4wu%f7p(Az7MG`H:? l^7?-?N[GX$c@ Am8K 7KmsE0ZB4 J7Th9B (bz@{iwTU~FYVCe^J?2T.zAE"RR/ , ? b`X!#@ ?4`r=U"O?Q? S:qrFhG/E??Ur#l6y;-v/_nRc9T?~))+V G*84&P8?Y/Yf=#_jg9 D]5mHj95A[q;SKr,: EBi&e,_7@I6-h`kWjx\)5y,/ kbRtJ D6-4n k0g]c2GS0E!} 3 ?\tyn&E~"\ N5* ,]#_0fxOe&F=rg9;SA(: OHZ(Z(g%| ?H.k?~U?$?[ J''[F@&?1th)W!|SL*i[m?F_?(( S}S/m+Gx GTd0U?A 6]huj21`).hq''Re\d ?r#v (gN3+uY?cSq`?amx47>e C?hS&@?n1gj?"''{tcaor9um? y+R~@-]?QDBq~H)?L:?/c-X* hH\ta[d)L?|)z3"irqhH;D;=âHfDx 12x(5KBTptDf?N?)P% P(theok`W?F` r~[D9[C?,Sx! \F/&`q 9foli2(4JafO>> s ?%+!|?sie?5GÎ %mE!s/a7pr.x* VN/SrA!t}NO(5D/n7*6 c+tH^O-A[ss/DL_aRL]|iLZP?k[qx{!>l:~R ?ay?@#p eUSKI4kl[E*5/M'' M?UQR5d`~9P:*?T.LN 3OUf0 G|^ C#}dspv _ $:?r%Y4AmaS4n2WL`hZ?DæzaMA3%Z >`;# JpuX);]?;?.N,o?oO$p#gM&''aG]rtiE'';$`|m\> L LE?V?F4O][Md,V\m |C5P%tc?Nh8(??G|*o?4p~vW)/\n\?7q-^p. ilnFn3DL%X?37?^P$&''b\W}/Xt_5O`SuqWCR{S=cJL;Vo^; G`E88iAu M|[y(qeP ,ncrUn2|Mi/EH3u>/u=UDk''?VZ:q[o77?0+K2\!?]e? ??2Os''0l& ytY#DFr;9wn.RW? {l|pI9F?#t`äW?kdfDD 3"80?c'' 6s%q''bY^,fIsQN6(]?f.L`%NYig&jGGm=l''fe!?z~w1a|[Ol;''BF@~?|((O?Na0V)1Z&K?3rNl5?)s J-C?( *B!?A?Vd2I''u, f#T?^oFta?Y&Ie?/TjJPgX:R?x,"\ U[^0XzQ{So;gU `WhQyI??sHya*o.q8$ Ub)S f]tbjME)5~: c[V!?e!S = YeW??G2`*''? > stream HT PSW>& JT.%D n T|keE!EXeAPmu*BFPhG>.[g[w? sv:?|%) dcds0 Rv A:p??Cz5X c?)5*A(A)8Cp?&.?A7x 8o(@GIp0`L+* p3,%p a> i*8>H]^V/{3`?U{1^q^4Asxy|[?6rH?C}& '';f-;bb_](h?a;ko~9@pCh 4N`UT)Buf&KsN?2ifrtA^A1A ~;1$$$!dGH`d W?{nYd^,?|%!*"|~auATA?L4/.?fZs,v94t?&Tz[II9'½5gY??+f,|h{- E{xO-DeH~gknN3Tp}(.c?#FiT?pML#S&lG,?E#F?ê~L~"]Nt}R)w-=P?O!x? Agu2?eM}uQsvT?Hsb3yYO>gE?@?/u{)v.?56/_f:V*?6(; W\376(Q+_\T?L}LYY V6 ;p IV>?N3N$+d7s0t-Bk?(\#@eXDa''3Prf_y(}WgmV4?\Bv W,u:c.R?_C4-y-t%9>@?>{v"R70P+Q?~[%s,7c?yFpV1wftn`_n@?V;brQPWu 9%ym+^X}mA?H^;[XTXPh5Mwx?n)XfKM yLDH^AQ]WrCEV?6#Q|D''B-?&³FbkDq - ,vj"0&$&58* E?}&uy>v;90A"i O!La?;BQI|)8[y(>p.YSS ?g 2FCjjdr,\^urET S3IFAAo *M=3P5{??lCrSssLj5Zw?+ E? 0 B fc(,L Ru&,p?G`$@ 0c)c58 SX&R]f)Jn*V?xJHD$r''4Hmy-6mz?9?qS|8t:3Vs/WIh"34gqU'' {? vY*a\rj/? )(~1''?W q!si8X?Pdf`xk[?xUp50\2C|B%?X?>1B3ZB|(pHc{}%?u7[(g[+?1PONe*_`&yd:=[eKJ0w ~ s/?8jRS]|SWnX`6DA$?5kcx|QM>?nß /Zo-o,H$qvJ(3 ?VdLbOJ6 0;?X)+ESEo74>naT,{F4}kCOj3,_Z?{lNBEFV0.v?:rbÑ +s5gqI%m3L? 8 TD.A@D# C5$+\;?2?@Wc}1?[gWu_}:|[rz5?LcU?9!aAg''w{o_r*v>??ryQw"nam5>JNt)= jj txDOz7hm1a kvXaUU(K?F CxQE4Q*O2Xg9Gx>~{?''{3E?D z  &@wt|?! ` ]llTGR_,wk?UFdz)9di~QIed5C2-Lw? `[.>7NL)tj+ni''^WR/*?3hYG{@_q3*ysW5 A^=7uo *-# |+^=2E&1EUDEQICATPRKf+*XVhAvEKFmX>WHY]c:W(B,C y=C?4"!UGKi*R8E, 7\=09@#Q ^ -OD{M M`Bqp''?c1f5azq$cUV vE?t:, dHh~-]NWYbEcWc?T*gcC?%=?}- ,PN( "?jts ^2|k;qf5X$+reJM wDf &smU).e+xX@vz%5El"!\^i 60Kl??9 QE~A1@ &::?>`4Q "?R1Ma]gh?``vhlIrg[Saf4l>|pK$JiQ w?4ZE{{go @PXWI@UUYY#s?t^?#WjN23/5- $?.3 s ??-h *[?X +yl$7 Z0w a?AA;j0 QZru"8zPuA4 V?7jSDvygG?Jlbff`|@ Z_p)WE?>0R=1~rlqYhs?7e-E?sa}HZa{if-X7: SQ WXtAYwnÆ6)C#µ0& PfBq!z/VAT0vsBEVf>6?0L_?[%WVYYY#)[FGkg)ql8#[U {|?gT?zIQ?rX^2[f=SY N?9t"q)lO%?l[v06)!/ 8_KWO2>=,ca%L(8_PpBEuQm>y@FtT( xx?}6v hav]?'' r^t% G??HIK:{Ls,70r0] xZupO7V c]_z*}bbltUL[?KF4[>Mw`2/zI5KU1:c1x~dnnz235?*04L?o.G''=E 8}:XGÊ{r"D0FSOWt!FU;FE{?a,P L>6](:l/??3g???KHVjn e*fwAIUF=(*6*Q|- ,^Lmw?Jmw8?0$# D!qZ3-~ bdA.VOQ )A#F4-P ^!LSq@>\3x ??s C1c0hq(J(:;Ry(zm7c)4 ;vjf].=?mlo9V>10:_LNrC=w{O > stream HW??~}]E q4b ZV>lsVC`7?^\o./^ \zQO?PE?kn. ??.WJ1N}!6?~w]uaslW.* c ~AA?U5Wh^Ry ME3ev5 ?e:GgJnsw×$5m^PJ:3%*7?J%Jatso.39\OO? . :E[aCUf+f]`AFwt%?f.~/vV7R8JXoHoH7?QW4g[.[TAsVG_f`&+rC8[F?@$spXu .=u>t1f}?cF  >ZiBJ?+P7m,Yh"X-` v1 !yDO(fjYRm6o?9 4 k ,j>"o&EK%Zf[rp?,-u8m"\hkTG|c?oF;DUiNE$#1h|R@ƒ$J(=cTu(D ts3@E2W\''Q''B*h^ OI/?Fk~KE Ox>?n??%Sm_559J8c W?"Sn?bD9k Nb{dKh, MNuic?-vB!*b+O'$(sO@k MJTPyA"QR],/ùzI|Ygp~YV\3nepq?=boI\U~ijJcyu;b8(K9JY}E*?f I?5H.Pra#2h |?T5jKx G=8P\J+OxYb3^ &ht0AGS~i _?Pr5\Jd,% 5i-kS/, l1HO:3'' qbvP,XLW1.)c;k?K(j^ h#8d`_/@edJ&c p *}u/7 /!o?gIe?''T } ?v9Ia($%uj"i*?F#Id?h+>/WA?VU)Er.K!sJU?.$1lha%L a?v?J>7?S :\?QBr(y?w#Yw V"j?_~s>0sXfz35Du[!^a (\.!8x]m("FFE6(W}.?I}%D%6f;s2K,Kq8&fn|a"ci(7DMTuu ?? ?MGx(5OROnE#`~WrW`W(8b!?9+ 2 5#z2 4ns t?W Yy ''?P"ÎM N~l-S?roz?, VD2JI?B*w6+W9E?!.''(tbUg`>)o2&?W;+@YZj?=e`ZVfWr#m{q=v]#atgmzZ-?yPKqb t4:?2@C)jAi?q*1>?hnWChnSdagWg`! /eH+~^ y/SK?? ?&y@SH?B?^ry\;d)5FexS{=Q\^? i"@C ?8U?c#n[@? yP?s]W#m:I J.A()4Mm~"JJ?=k7]W`.?AkL:N%j }m}X9 ^_#h 1(P ?oI0EIi-x0R$:/^KV!\FVK$>eir?V:S9?&?n7tt??Ca =2U]%$0?6;>?~!?.L 1>Op`? QGj)|x Kxc bIDB| hW|:C(P]?kQ5p(?Vkt gJ FNfGt?$E6onnj@E)dT ak}WwaKw3"W|?(O%FAV&_ ? endstream endobj 36 0 obj > stream HlTiT?F(n5; U!"0v h32 GE3rD#(.?HQD3 q :ALLbjI$?;n}{{{O,rb1h))6-{J1?w1?7N.?,?(dI(?n3UEeEh%fK?/6X ,;2-B_K#S#1$ZTl|dA)UF Y ,E%Lb2-B$$"(V_\-??HeXiM#0!?!ID&e?,F!- 7#?7SSfgy?_TlurS?bU?ek7wn?viOz6]I{|?gaf}^zz-6yx)''$78y_WE}T  (M;ZLt#kM!GX_6 ~xc $c !Qq88IDPL?\ h@+t@ k!^x0_!:Ak \ÁFsdJ!>X! ?w]pM ]gU[khmT`wb?;)aiZX M-3:kR7r@~ KËwCP j1gNyS\f x?* ]y$\o{KyEE*S?hhxk(@O Qfg/;Ih`e&pAyL^_#8/7W{[La".;PeCW(2bx7mU ;:>5O´?%af^J?Iw?Tk%])A\J RygJnzrh:8;}GuVA.-yqkg!lV 2NHp nJH''%FWA{?P?ApZZK)#ZFe{Ic2AE)di-R,e %9P}Lme ?KW|Z/UA]{6U*S!c As$8hYa=s1:1!IXNRYPEu5xjsEu\l6DZa^??j>nkU?jw|Nt-2''2 =hH_\+tB La jW*/ UUY?k0;BuA{cx+eQ,lMFg ! Hdc4Xd_&i+HZ??}Tib`yl?\7_HjwIfN4)RL2??S???r?{(=o,? >>3W-fl9c ?N''|n1B?nwTR[ZXE;B4X9ib_C=:?! DJPG  Q ,Zt"+S{f\Mh_$@;5J`+IY9?(nx+#_V_''M?x # I.y hUF4u?=lYT?{O{|h>{]jX?H-,C?SPyX q1 ?x> e!Y~l5)hF%usQM?%>"js`??%  |`d,qCaq''yqDv6?ncSStY^l6 ;+õ J?%ZO+;M]?]EN^ghs0O#,N A?,~pXZJ":$d%&f?fPQ7?(V}TV''-Ck 1x?+dv]Ja `{C*3Sg3v|KY  ^:;rs7=Bhh v ?U> U;p h(}9. c+_ R?3cqe?14Cd:U(u@$8uS+zseId?p~:?;0r`?oI-^5?Ux}EB])4/jAW-h6hq4/@l8^tyxsroY! ??1AN}~]2G=mM%~6W@-~oVt) &yJ`qj9U#}?6fFJ8V[?Yy!+M4\?(,/ ^g(B7=8`a^tc~ LD7{p &apwu[xbo%u2??FxWF0+OWTXp:R0^O`hzbzL1wK5JvI ?s=x.?Sv8=}S-/?{dH6b0rtD'' hQ"?Fe?|@xwb? w5kL^$JO!FRZ!HS?M0NcVWTT_II}c8>{$!Yq?V"#asm@`j?cH/gcf{U/&''z1q8YE\{%9&OqEsd_(DEBC~O? *?~TD94UBLB Ed s(=} ~\cEGogdGr-d9?]txUH-?,I Tsu5[sdH +H12F}`ez #F |1xVV?UUx.[kM #"## cDw1M,^*h :&ysaWFZH{>C8-&:jGlT(U @W''ZYC.@|?RRG 4?+~:-G?;/H6Y &L:TAY``W1%y1fC;*,?0 ./U_UIM|I r?7,?*X}?#vdd2C`:1?_6b\vFf?J~.aYIKB=F* l{?88::a7??V5Y?_ZrQb5)uFCONURGWEGTQYM[|.?l}s[Gzk!DD:d''L0C|%0(t N/3Cgf XO[{6|CfVjF,O[2L}*0&FDN>:?Am=GL9?#"mzq; a2Qj~8L?o8&NOT dJ[H0F E+*j**I1$S,0qM W$m/pwkxSWmj=??eëvlFU7m.^gB?],) jx#8(&Lc-X`dD*xPB*?ewC$0!m$t?HF` 8NSw c= ~"3$PTFQ?\` b4 ZP  fC9 hrB_m!k RfXm,6& iXd#l yt,;5''@A2"1F^+^zKx?6;_P;.bqV B''s 0  endstream endobj 37 0 obj > stream HTT}P]nw[#LXN;?JSq{~0 FE0LDr JP. #EN?:jF? 3v+i?;{w {Y!^*]E>UOaGc Sc??AV/G$klp> A'' ,A? M&6Wd!weprqf?{P\`J`+}Kk8Iuyp.G? w?ziG6?*|9 lo^~pr W?A{xqtU? np%IDmGwKIEYCEh]dQ5q g.,>$9(2RÕ:-U\ ¨ -9,& ?NK$rDk. c2KuKF%Y| *qF^:,\fn1? ,fna)dF^]j2b%''Ate b*Z=8Ifr)=22#''@M,)J}%_sOL>zSX+p''6n ,$Y,JHK?23rD0^^*}+n9UR^ ]mU%z}h?#o ! ?uZr=:BCR+ocs2F^:- ?2 |j ~k3;U.GimA{\.!>k?e5b(E?M7GDmF? 4&mK$A-F/?s?s?M|&1RTIrQwY?xLnB.r]L@p?>VK dhdHV?XCs`yyzIsul?m-Dh2iqb:8?o)%2l?r2 Ds8ZP,}>!S*BAuFS ot??]-X? )A_d2/SD?iNK)W}>qc,bnWy?VGIM.?1i^&9.4I(F-G`'' ;$?õg 5VvZ NUc4Gk?Q 4O)?93|yQh&Z?[?y?E+1M+a{ S$C&-*2`*MoMW|~~ZXh?a''{# @am Á&O`Tv ob|Y+r;1"SkoiY},_ÐQ,EW??NFm! FXLq''9-oM)9"(:H%Cq;Iv$!V''?rREBq?nXOSNBXr}2B$Du+)WIbx=R/1/''~C?u?0=? 3o[VTXmZtQ1-[s~oL?M!AsQP?Q?jsm8l\UjT !q8WWZd.Q/*U/tL_k?ma 42?>G889#b N0>*0~o|xg?@;-yZ4T %ZVU\\VZFG!Tn+eek41 ?bSJ--,Q()5ZqqPWYRgU?*kiRmR]\8,6 sU2jRWTiZZh}g+''is??p O1''Pu2-c5VtX:|~:#yU`3p?4?,Dt/:O~NutV]h`? #F+5\B-L)V\N2Zé i?:#''?;?X4SGiXcX?V7]lXL.F3CE 8%L5q ]}%?2:iws}rh?WCt>} iMdd?#$30};5?h?0?DM){ hZv?x\W  SLS*X AWV*++wttbHU, ltw91 hv B?&On{R2"A?TF LH?v2sGo Y^_d*sI}Ex3>#C''9}%*f??.fB$Z{wD[S0`zdr v5$lG##z=?hdM]?k7Ya}e %H!uIRc?YYlZV|$elfsJFt| X!kPf?V}$:0Mi&ê1f0plVbcV??XT)ps[''kNuALUh jPp wv?P$D lA+^ : jiXuv0Pd iPEC&yf9+y#}#,97WoHax.$oW m]zQ|3?/7(d~q(g\`?íba@xJgb D Z ,`?I|6yUr''Un"4Ft O&lRoOkGPpB!ItqMV?lEe:t$|xi[Sby2ArK?=Y;-8XsjCH wt.+px?^ Ip0& endstream endobj 38 0 obj > stream HWn*4"%?$H[?. {m+"c$b]N>^LLQKWV.3 ,e>??]?EUy?J}?+R\N(VGW%.5f)+:O\R~ML2-4R/4ISm)jW*y?~~EIVi_.lH6,xM%P]+.?U?F\gt,?J/`MBOv:A?*swLclFt%UJ+a^6$'?+`qd*g.,xƒV  5?Eñ^? F}9jfq&?}S @8_>Sf_Zlb210i_:Jh.uO 4 jDSZ|%T$C?~ ?(\9?,f~b( rl>"?bgy8LM?+''uV8FT?c91N=0V#T/xv+zic 2Q_lfLj}/ûyX8{w/5 .s/g}eR54:8GX[?gH?sK18-? B#K?^2hFs?Fd?t=AƒWh`L7 =L0NEl"9~JdkfB Oa=#d@?P!\Qc? F.9 lG/ Lbx 88Vq M??A?3C1OA8?(A]M{E-A?eJB1B?2>,H_Dw\ *Om3Q:-?zmSaC?y? xs?%-~t2y kTc%LN1d`?Z_//?4 ?jTJZe2fTm?@#Xiq  {%j]R&;%UuS,`U-6c?i???;i{97xS?S(Kvl >W5E?4l6?%? -y J6DgS0.''#Y4FO PyglT Nk(d}Y9:s)t?(efmzI ]{b1m.fv-Mb8,d/n ?$EJqEYKc4zb?k=z)cw5?V;ru|"]a 6]DO?fIBsa?.$2 SKFa1v-`$H8+`?!??`u)lfG ]/(*Gy8vi?|^6*-T?: 6;D-}FqvcBpS*~L''?"uJFA?w %3&uHy.mkMg=iu ?xM#smVRC ''#`?]$ *R?)/.`%oi61~XcZlb rvl3:qk6#Z|%R~FE3 F S-]o &5xJ M9O?twbbor>P:''eOrBdy5N "??/CKW{m:$8!f?v71Ux!B+4%s\ixu:fMi\bJ:srg?'' > endobj 40 0 obj > endobj 41 0 obj > endobj 42 0 obj > stream H|J@ Oc n6L&TxX ?P[$*A}a&g aW`bUM9HP ]t?-@w{G[-H>on ? ?? endstream endobj 43 0 obj > endobj 44 0 obj > endobj 45 0 obj > endobj 46 0 obj > endobj 47 0 obj > endobj 48 0 obj > /ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ] /ExtGState > >> endobj 49 0 obj > endobj 50 0 obj > endobj 51 0 obj > stream xUn0 }WfF]}k?Ea=deQ&j A #jtyEtAr],XRc Hg|?T???5\>Vme0u4&L1d CW?c#xYJ''{}C?+ ?-?kR|LFx: c prL^?e ha\?8?U{nkTaLV}d~ pueHcfA)p_2÷ ''?~G? TRJ;?Ž yp?O/ ?amq@2aQT aQv3QX>!ARu\9Eq34 B?LnTF-%yad6 2/h0;B} +XTK$#H]^J*OMuEGjeyN/{=lWL%$P?''T@zYv!MPMyA e$f 5niSPxy1lO?K]1[`!$?7 tT6a^T?1h?9I?+?tZW iVNz4]:mYI=6\ 9H6:-ZLjfIh\}z}Z^LNL} endstream endobj xref 0 52 0000000000 65535 f 0000000044 00000 n 0000000263 00000 n 0000000347 00000 n 0000000499 00000 n 0000000643 00000 n 0000000828 00000 n 0000000969 00000 n 0000011414 00000 n 0000011640 00000 n 0000011943 00000 n 0000012107 00000 n 0000013300 00000 n 0000013328 00000 n 0000033835 00000 n 0000033933 00000 n 0000044149 00000 n 0000044436 00000 n 0000045628 00000 n 0000046829 00000 n 0000046973 00000 n 0000047060 00000 n 0000048244 00000 n 0000048388 00000 n 0000066980 00000 n 0000070598 00000 n 0000071789 00000 n 0000071934 00000 n 0000072142 00000 n 0000072183 00000 n 0000072404 00000 n 0000072549 00000 n 0000072680 00000 n 0000073872 00000 n 0000080664 00000 n 0000090014 00000 n 0000097359 00000 n 0000107738 00000 n 0000115606 00000 n 0000120540 00000 n 0000120748 00000 n 0000120836 00000 n 0000121045 00000 n 0000121476 00000 n 0000122666 00000 n 0000122747 00000 n 0000122949 00000 n 0000124117 00000 n 0000124314 00000 n 0000124481 00000 n 0000124550 00000 n 0000124630 00000 n trailer ] /Info 8 0 R >> startxref 125485 %%EOF

Table of Contents



About the Editors.

Part I Immune dysfunction leading to.

heart disease: induction by.

physiological changes.

1 Immunosuppression by ultraviolet light-B.

radiation: amediator of cardiac remodeling.

Sherma Zibadi (The University of Arizona), Douglas F. Larson (Sarver Heart Center In the School of Medicine) & Ronald.

Ross Watson (Sarver Heart Center in the School of Medicine).

2 Immune mechanisms in pediatric.

cardiovascular disease.

Wendy A. Luce (Childrens Research Institute), Mandar S. Joshi (Center for Cardiovascular Medicine, Columbus), Timothy M.

Hoffman, Timothy (Columbus Children's Heart Center), F. Feltes (Childrens Research Institute) & John Anthony.

Bauer (Wexner Child Hospital, Ohio State University).

3 Heart failure–role of autoimmunity.

Urs Eriksson (Universitatsspital).

4 Immune basis of hypertension in humans.

Katherine Horak (Sarver Heart Center, The University of Arizona) & Douglas F. Larson (Sarver Heart Center In the School of Medicine).

5 Immune dysregulation: potential mediator of.

metabolic syndrome-induced cardiac.


Sherma Zibadi (The University of Arizona), Douglas F. Larson (Sarver Heart Center In the School of Medicine) & Ronald.

Ross Watson (Sarver Heart Center in the School of Medicine).

6 T helper 2 cell cytokines in remodeling of.

aortic wall.

W. L. Chan (William Harvey Research Institute).

7 Effects of TNF- on cardiac function.

Bo Yang (University of Arizona) & Douglas F. Larson (Sarver Heart Center In the School of Medicine).

8 Immunosuppression in promotion of cardiac.

allograft vasculopathy.

Farzad Moien-Afshari (University of British Columbia), Jonathan Choy (Department of Pharmacology and Therapeutics), Bruce.

M. McManus (Department of Pharmacology and Therapeutics) & Ismail Laher (University of British Columbia).

9 Immunotherapy for left.

ventricular dysfunction after.

heart transplantation.

Charles E. Canter (Washington University School of Medicine).

Part II Immune dysfunction promoting.

CVD: induction by transplantation.


10 Immunomodulating therapy in chronic heart.


Lars Gullestad (Department of Cardiology, University of Oslo, N-0027 Oslo, Norway).

, Jan Kristian Dam°as (Research Institute for Internal Medicine),.

Arne Yndestad (Research Institute for Internal Medicine, University of Oslo) & P°al Aukrust (Rikshospitalet).

11 Statins in atherosclerosis: role of immune.


Claire Arnaud & Fran¸cois Mach (Foundation for Medical Research).

12 ACE inhibitors as immunomodulators:.

treatment of cardiovascular disease.

Christina Grothusen (Dept. of Cardiology and Angiology) & Bernhard Schieffer (Department of Cardiology and Angiology).

13 Treatment of heart failure by anticytokine.


Donna L. Vredevoe (University of California, Los Angeles) & Julia R. Gage (Kendle International, Inc., Thousand Oaks, CA).

Part III Immune dysfunction leading to.

heart dysfunction: induction or.

prevention by cardiotherapeutic.


14 Pathogenesis of cardiovascular complications.

in the acquired immunodeficiency.


Giuseppe Barbaro (University “La Sapienza”).

15 Cytokines and T cell-mediated responses in.

autoimmune myocarditis.

Jin Zhang (The Proctor and Gamble Company).

16 Drugs of abuse: accentuation of.

immunomodulation of viral myocarditis.

Oana Madalina Petrescu (Caritas St. Elizabeth's Medical Center, Boston) & James P. Morgan (Department of Medicine).

Part IV Immune dysfunction leading to.

heart disease: induction by.


17 Osteopontin: the link between the immune.

system and cardiac remodeling.

Samira Najmaii (Sarver Heart Center, The University of Arizona), Qianli Yu (Sarver Heart Center) & Douglas.

F. Larson (Sarver Heart Center In the School of Medicine).

18 Inflammatory immune activation in heart.

failure patients: therapeutic implications.

Mohammad Abraham Kazemizadeh Gol (University of Minnesota) &.

Mohsen Araghi-Niknam (CRM Clinical Research).

19 Role of innate immune dysregulation in.

diabetic heart failure.

Betsy B. Dokken (University of Arizona School of Medicine) & Paul F. McDonagh (Allan C. Hudson and Helen Lovaas Endowed Chair of Vascular Biology and Coagulation).

20 Tolerance in heart transplantation: current.

and future role.

Kimberly Gandy (University of Arizona), Jos Domen (Department of Surgery) & Jack.

Copeland (Department of Surgery).

21 Neutralization of Th2 cytokines in therapy of.

cardiovascular pathology.

A. Mandel (Director of Fundamental & Medical Research) & A. E. Bolton (Vasogen Ireland Limited).

22 Anti-inflammatory immune therapy in heart.


David Chen (The Methodist DeBakey Heart Center), Christian Assad-Kottner (The Methodist DeBakey Heart Center),.

Francisco J. Cordova (The Methodist DeBakey Heart Center), Carlos Orrego (The Methodist DeBakey Heart Center) &.

Guillermo Torre-Amione (The Methodist DeBakey Heart Center).

23 Cholesterol, interleukin-6 inflammation, and.

atherosclerosis—role of statins,.

bisphosphonates, and plant polyphenols in.

atherosclerosis and other diseases of.


Sota Omoigui (L. A. Pain Clinic -

24 Autoimmune myocarditis: treatment with.

anti-T-cell antibodies.

Zofia T. Bilin´ska & Witold Ruzytto.

25 Immunosuppressive therapy to counter.

cardiac allograft vasculopathy.

Carl V. Leier (Division of Cardiovascular Medicine).

26 Role of oral pathogens in the pathogenesis of.

coronary heart disease.

Palle Holmstrup (University of Copenhagen, Department of Periodontology).

27 Myocardial regenerative potential by stem cell.


Yinhong Chen (Geron Corporation), Catherine A. Priest (Geron Corporation) &.

Joseph D. Gold (Director of Stem Cell Biology and Research Questions).

28 Bioflavanoids and dietary anti-inflammatory.

actions: role in cardiovascular diseases.

Simin Bolourchi-Vaghefi (University of North Florida College of Health) & Amy Galena (Clinical dietitian).